Cancer Research & Innovation
Browse our collection of health resources and expert insights.
New Year, New Hope for Triple Negative Breast Cancer Patients: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationPromising news has arrived for women throughout greater Los Angeles who have been diagnosed with triple negative breast ...
New studies show the benefit of exercise and yoga in breast cancer survivors: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationAs Hematologists and Medical Oncologists, Dr Lashkari, Dr Shaye and I are often asked about the importance of exercise i...
New Myeloma Drug FDA Approved: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationThe FDA just approved Pomalidomid, Pomalyst, for treatment of multiple myeloma in patients who have previously been trea...
New Medication in Chronic Lymphocytic Leukemia shows promise in phase 3 clinical trial: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationSince the average age of patients who are diagnosed with chronic lymphocytic leukemia is 75, patients who are diagnosed ...
New Development in Prostate Cancer Treatment: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationProstate Cancer is the most common cancer diagnosed in men in the United States. 240,000 men were newly diagnosed in 201...
New Development in gastric/stomach cancer and associated cancer: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationStomach cancer also known as gastric cancer are unusual cancers in North America, but not the rest of the world. Esophag...
May is Skin Cancer Awareness Month: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationAs we prepare for our the annual cancer walk in Calabasas, I wanted to raise awareness about skin cancer. Skin cancer ha...
Leukemia: Common Types, Symptoms & Treatment in Southern California: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationLeukemia is the general name for all types of cancer which affect the blood and the bone marrow. When a person’s b...
FDA approves Xalkori (Crizotinib): Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationAs part of our recognition of November being Lung Cancer Awareness Month, Dr Omid Shaye, Dr Ashkan Lashkari and I would ...
FDA approves Imbruvica (ibrutinib) to treat chronic lymphocytic leukemia: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationIn keeping our patients informed of the latest developments, I wanted to share with you a late breaking development. We ...